Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$141.0M
+3.3% from 2023
Prescriptions
137K
$1,031.60 per claim
Patients
29K
17,386 prescribers
Total spending, 2024
$141.1M
$4,910.74 per patient
Medicare prescription drug plans paid $141.0M for Glyxambi in 2024, for 136,680 prescriptions and refills to 28,712 patients (up 3.3% from 2023). The average cost per claim was $1,031.60.
Puerto Rico had the highest Medicare cost for Glyxambi in 2024: $19.1M for 23,241 claims, followed by Florida ($16.8M).
Hung T Dang, internal medicine in Houston, TX, had the highest Medicare cost for Glyxambi in 2024: 173 claims costing $268K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Hung T Dang Houston, TX | Internal Medicine | 173 | 54 | $268K |
| Norma I Vergne Santiago Juana Diaz, PR | Internal Medicine | 407 | 78 | $265K |
| Jose A Curet Ramos |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 15,208 | 111,835 | 24,233 | $114.2M |
| 2023 | 16,527 | 124,327 | 27,106 | $136.6M |
| 2024 | 17,386 | 136,680 | 28,712 | $141.0M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 390 |
| 56 |
| $263K |
| William Vega-Ocasio Cayey, PR | Nephrology | 399 | 59 | $258K |
| Dalitza M Alvarez Valentin San Juan, PR | Endocrinology | 281 | 66 | $238K |
| Antonio Marrero Miami, FL | Nurse Practitioner | 196 | 58 | $234K |
| Samayra Miranda Rodriguez Dorado, PR | Endocrinology | 269 | 55 | $231K |
| Juan D Palacios Merchan Edinburg, TX | Endocrinology | 230 | 53 | $228K |
| John D Crawford Germantown, TN | Family Practice | 228 | 45 | $228K |
| Wallace Belmont Rodriguez Caguas, PR | Internal Medicine | 340 | 43 | $222K |
| Ariel Martinez Watsonville, CA | Family Practice | 187 | 54 | $218K |
| Yuan Zhang New York, NY | Nurse Practitioner | 220 | 54 | $213K |
| Sheila Mercado Manati, PR | Endocrinology | 301 | 52 | $211K |
| Ralph M Cincinnati Wyomissing, PA | Nurse Practitioner | 213 | 40 | $199K |
| Nhanhau Ngo Garden Grove, CA | Family Practice | 203 | 33 | $195K |
| Duc H Phan Houston, TX | Internal Medicine | 187 | 49 | $195K |
| Enrique J Griego McAllen, TX | Family Practice | 142 | 36 | $191K |
| Oberto Torres Rafael Miami, FL | Endocrinology | 248 | 41 | $184K |
| Manuel Alegre-Hernandez San Juan, PR | Endocrinology | 151 | 39 | $179K |
| James H Barnett Midland, TX | Interventional Cardiology | 136 | 37 | $178K |
| Hugo Yamada Lincoln, RI | Internal Medicine | 233 | 38 | $176K |
| Javier L Tirado Manzano Dorado, PR | Internal Medicine | 249 | 37 | $173K |
| Juan L Ortiz Matos Corozal, PR | Internal Medicine | 229 | 28 | $169K |
| Lionel Velez Montijo Bayamon, PR | Internal Medicine | 237 | 44 | $168K |
| Mark M Song Los Angeles, CA | Internal Medicine | 194 | 30 | $164K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Boehringer Ing. | 136,734 | $141.1M |